142 related articles for article (PubMed ID: 33945927)
21. The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine.
Sun Y; Drevets W; Turecki G; Li QS
Brain Behav Immun; 2020 Jul; 87():404-412. PubMed ID: 31978524
[TBL] [Abstract][Full Text] [Related]
22. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
[TBL] [Abstract][Full Text] [Related]
23. Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging.
Joensuu M; Tolmunen T; Saarinen PI; Tiihonen J; Kuikka J; Ahola P; Vanninen R; Lehtonen J
Psychiatry Res; 2007 Feb; 154(2):125-31. PubMed ID: 17289353
[TBL] [Abstract][Full Text] [Related]
24. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
[TBL] [Abstract][Full Text] [Related]
25. CSF miR-16 is decreased in major depression patients and its neutralization in rats induces depression-like behaviors via a serotonin transmitter system.
Song MF; Dong JZ; Wang YW; He J; Ju X; Zhang L; Zhang YH; Shi JF; Lv YY
J Affect Disord; 2015 Jun; 178():25-31. PubMed ID: 25779937
[TBL] [Abstract][Full Text] [Related]
26. Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder.
Savitz J; Dantzer R; Meier TB; Wurfel BE; Victor TA; McIntosh SA; Ford BN; Morris HM; Bodurka J; Teague TK; Drevets WC
Psychoneuroendocrinology; 2015 Dec; 62():54-8. PubMed ID: 26232650
[TBL] [Abstract][Full Text] [Related]
27. Quantifying midbrain serotonin transporter in depression: a preliminary study of diagnosis and naturalistic treatment outcome.
Tsai HC; Lin SH; Chen PS; Chang HH; Lee IH; Yeh TL; Chen KC; Chiu NT; Yao WJ; Liao MH; Yang YK
Pharmacopsychiatry; 2015 Mar; 48(2):58-64. PubMed ID: 25626060
[TBL] [Abstract][Full Text] [Related]
28. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
[TBL] [Abstract][Full Text] [Related]
29. The kynurenine and serotonin pathway, neopterin and biopterin in depressed children and adolescents: an impact of omega-3 fatty acids, and association with markers related to depressive disorder. A randomized, blinded, prospective study.
Ilavská L; Morvová M; Paduchová Z; Muchová J; Garaiova I; Ďuračková Z; Šikurová L; Trebatická J
Front Psychiatry; 2024; 15():1347178. PubMed ID: 38414497
[TBL] [Abstract][Full Text] [Related]
30. Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder.
Cathomas F; Guetter K; Seifritz E; Klaus F; Kaiser S
Sci Rep; 2021 May; 11(1):9992. PubMed ID: 33976271
[TBL] [Abstract][Full Text] [Related]
31. The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder.
Öztürk M; Yalın Sapmaz Ş; Kandemir H; Taneli F; Aydemir Ö
Int J Clin Pract; 2021 Apr; 75(4):e13739. PubMed ID: 32997876
[TBL] [Abstract][Full Text] [Related]
32. Probing the association between dexamethasone-induced cortisol suppression and serotonin transporter availability among drug-free patients with major depressive disorder--a small-sample SPECT study with [¹²³I]ADAM.
Tsai HC; Lin SH; Lee IH; Chen PS; Chen KC; Yeh TL; Yao WJ; Chiu NT; Lu RB; Yang YK
Psychoneuroendocrinology; 2013 Nov; 38(11):2805-9. PubMed ID: 23816429
[TBL] [Abstract][Full Text] [Related]
33. (13)C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder.
Teraishi T; Hori H; Sasayama D; Matsuo J; Ogawa S; Ota M; Hattori K; Kajiwara M; Higuchi T; Kunugi H
Sci Rep; 2015 Nov; 5():15994. PubMed ID: 26524975
[TBL] [Abstract][Full Text] [Related]
34. Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression.
Rajkowska G; Mahajan G; Legutko B; Challagundla L; Griswold M; Albert PR; Daigle M; Miguel-Hidalgo JJ; Austin MC; Blakely RD; Steffens DC; Stockmeier CA
Neuroscience; 2017 Sep; 359():30-39. PubMed ID: 28711621
[TBL] [Abstract][Full Text] [Related]
35. Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis.
Ogawa S; Fujii T; Koga N; Hori H; Teraishi T; Hattori K; Noda T; Higuchi T; Motohashi N; Kunugi H
J Clin Psychiatry; 2014 Sep; 75(9):e906-15. PubMed ID: 25295433
[TBL] [Abstract][Full Text] [Related]
36. Frontostriatal circuitry and the tryptophan kynurenine pathway in major psychiatric disorders.
Liang S; Zhao L; Ni P; Wang Q; Guo W; Xu Y; Cai J; Tao S; Li X; Deng W; Palaniyappan L; Li T
Psychopharmacology (Berl); 2024 Jan; 241(1):97-107. PubMed ID: 37735237
[TBL] [Abstract][Full Text] [Related]
37. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
[TBL] [Abstract][Full Text] [Related]
38. An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder.
Pu J; Liu Y; Zhang H; Tian L; Gui S; Yu Y; Chen X; Chen Y; Yang L; Ran Y; Zhong X; Xu S; Song X; Liu L; Zheng P; Wang H; Xie P
Mol Psychiatry; 2021 Aug; 26(8):4265-4276. PubMed ID: 31959849
[TBL] [Abstract][Full Text] [Related]
39. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
[TBL] [Abstract][Full Text] [Related]
40. Tryptophan and Kynurenine Metabolites: Are They Related to Depression?
Pompili M; Lionetto L; Curto M; Forte A; Erbuto D; Montebovi F; Seretti ME; Berardelli I; Serafini G; Innamorati M; Amore M; Baldessarini RJ; Girardi P; Simmaco M
Neuropsychobiology; 2019; 77(1):23-28. PubMed ID: 30110684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
